A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes

Experimental Cell Research

Volumn 312, Issue 13, 2006, Pages 2465-2475

  Sandoval, Raudel ^a   Xue, Jiaping ^a   Tian, Xinyong ^a   Barrett, Kelly ^a   Pilkinton, Mark ^a   Ucker, David S ^a   Raychaudhuri, Pradip ^a   Kineman, Rhonda D ^a   Luque, Raul M ^a   Baida, Gleb ^a   Zou, Xianghong ^a   Valli, V E ^b   Cook, James L ^a   Kiyokawa, Hiroaki ^a   Colamonici, Oscar R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

BARA; CDK; Cell cycle; Cyclin; LIN 9

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLINE; LIN 9 PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; MAMMAL CELL; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 33745967001     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.04.002     Document Type: Article

References (39)

1. Sherr C.J., and Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 (2004) 2699-2711
2. Attwooll C., Lazzerini E., and Denchi K. The E2F family: specific functions and overlapping interests. EMBO J. 23 (2004) 4709-4716
3. Blais A., and Dynlacht B.D. Hitting their targets: an emerging picture of E2F and cell cycle control. Curr. Opin. Genet. Dev. 14 (2004) 527-532
4. DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta 1602 (2002) 131-150
5. Stevaux O., and Dyson N.J. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14 (2002) 684-691
6. La Thangue N.B. The yin and yang of E2F-1: balancing life and death. Nat. Cell Biol. 5 (2003) 587-589
7. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
8. Frolov M.V., and Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117 (2004) 2173-2181
9. Dimova D.K., and Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24 (2005) 2810-2826
10. Hurford Jr. R.K., Cobrinik D., Lee M.H., and Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11 (1997) 1447-1463
11. Leng X., Connell-Crowley L., Goodrich D., and Harper J.W. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7 (1997) 709-712
12. Yu B.D., Becker-Hapak M., Snyder E.L., Vooijs M., Denicourt C., and Dowdy S.F. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14881-14886
13. Skapek S.X., Rhee J., Kim P.S., Novitch B.G., and Lassar A.B. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16 (1996) 7043-7053
14. Zwicker J., Brusselbach S., Jooss K.U., Sewing A., Behn M., Lucibello F.C., and Muller R. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation. Oncogene 18 (1999) 19-25
15. Datar S.A., Jacobs H.W., de la Cruz A.F., Lehner C.F., and Edgar B.A. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 19 (2000) 4543-4554
16. Meyer C.A., Jacobs H.W., Datar S.A., Du W., Edgar B.A., and Lehner C.F. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J. 19 (2000) 4533-4542
17. Bruce J.L., Hurford Jr. R.K., Classon M., Koh J., and Dyson N. Requirements for cell cycle arrest by p16INK4a. Mol. Cell 6 (2000) 737-742
18. Matsuura I., Denissova N.G., Wang G., He D., Long J., and Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430 (2004) 226-231
19. Deshpande A., Sicinski P., and Hinds P.W. Cyclins and cdks in development and cancer: a perspective. Oncogene 24 (2005) 2909-2915
20. Gaubatz S., Lindeman G.J., Ishida S., Jakoi L., Nevins J.R., Livingston D.M., and Rempel R.E. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell 6 (2000) 729-735
21. Gagrica S., Hauser S., Kolfschoten I., Osterloh L., Agami R., and Gaubatz S. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein. EMBO J. 23 (2004) 4627-4638
22. Beitel G.J., Lambie E.J., and Horvitz H.R. The C. Elegans gene lin-9, which acts in an Rb-related pathway, is required for gonadal sheath cell development and encodes a novel protein. Gene 254 (2000) 253-263
23. Beall E.L., Bell M., Georlette D., and Botchan M.R. Dm-myb mutant lethality in Drosophila is dependent upon mip130: positive and negative regulation of DNA replication. Genes Dev. 18 (2004) 1667-1680
24. Korenjak M., Taylor-Harding B., Binne U.K., Satterlee J.S., Stevaux O., Aasland R., White-Cooper H., Dyson N., and Brehm A. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119 (2004) 181-193
25. White-Cooper H., Leroy D., MacQueen A., and Fuller M.T. Transcription of meiotic cell cycle and terminal differentiation genes depends on a conserved chromatin associated protein, whose nuclear localization is regulated. Development 127 (2000) 5463-5473
26. White-Cooper H., Schäfer M.A., Alphey L.S., and Fuller M.T. Transcriptional and post-transcriptional control mechanisms coordinate the onset of spermatid differentiation with meiosis I in Drosophila. Development 125 (1998) 125-134
27. Boxem M., and van den Heuvel S. C. elegans class B synthetic multivulva genes act in G1 regulation. Current. Biol. 12 (2002) 906-911
28. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., and Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity. Mol. Cell. Biol. 19 (1999) 7011-7019
29. Pei X.H., Bai F., Tsutsui T., Kiyokawa H., and Xiong Y. Genetic evidence for functional dependency of p18Ink4c on Cdk4. Mol. Cell. Biol. 24 (2004) 6653-6664
30. Sandoval R., Xue J., Pilkinton M., Salvi D., Kiyokawa H., and Colamonici O.R. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. J. Biol. Chem. 279 (2004) 32275-32280
31. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., and Weinberg R.A. Effects of an Rb mutation in the mouse. Nature 359 (1992) 295-300
32. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., and Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev. 14 (2000) 3037-3050
33. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., and Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 22 (1999) 44-52
34. Moons D.S., Jirawatnotai S., Tsutsui T., Franks R., Parlow A.F., Hales D.B., Gibori G., Fazleabas A.T., and Kiyokawa H. Intact follicular maturation and defective luteal function in mice deficient for cyclin-dependent kinase 4 (CDK4). Endocrinology 143 (2002) 647-654
35. Moons D.S., Jirawatnotai S., Parlow A.F., Gibori G., Kineman R.D., and Kiyokawa H. Pituitary hypoplasia and lactotroph dysfunction in mice deficient mice deficient for cyclin-dependent kinase 4. Endocrinology 143 (2002) 3001-3008
36. Martin J., Hunt S.L., Dubus P., Sotillo R., Nehme-Pelluard F., Magnuson M.A., Parlow A.F., Malumbres M., Ortega S., and Barbacid M. Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Oncogene 22 (2003) 5261-5269
37. Xue J., Tarnasky H.A., Rancourt D.E., and van Der Hoorn F.A. Targeted disruption of the testicular SPAG5/deepest protein does not affect spermatogenesis or fertility. Mol. Cell. Biol. 22 (2002) 1993-1997
38. Wynick D., Small C.J., Bacon A., Holmes F.E., Norman M., Ormandy C.J., Kilic E., Kerr N.C., Ghatei M., Talamantes F., Bloom S.R., and Pachnis V. Galanin regulates prolactin release and lactotroph proliferation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12671-12676
39. Moore Jr. J.P., Cai A., Maley B.E., Jennes L., and Hyde J.F. Galanin within the normal and hyperplastic anterior pituitary gland: localization, secretion, and functional analysis in normal and human growth hormone-releasing hormone transgenic mice. Endocrinology 140 (1999) 1789-1799